Skip to main content

Advertisement

Log in

Response to neoadjuvant therapy in locally advanced rectal cancer: assessment with diffusion-weighted MR imaging and 18FDG PET/CT

  • Published:
Abdominal Imaging Aims and scope Submit manuscript

Abstract

The aim of this study was to evaluate the correlation between the changes of SUVmax and of apparent diffusion coefficient (ADC) before and after neoadjuvant therapy, to enable us predict the therapy response, in patients with locally advanced rectal cancer (LARC). A total of 30 patients with LARC who underwent CRT were recruited for our study. All the patients underwent a whole body 18F-FDG-PET/CT scan and a pelvic MR examination including DW imaging for staging (PET/CT1 and RM1), and after the chemoradiation therapy (PET/CT2, and RM2). Histopathologic analysis of rectal specimen, according to tumor regression grade (Mandard’s criteria) was used as the standard reference. MR and PET-CT images were analyzed, and measurements of ADC values and SUVmax were taken. Diagnostic performance for selection of complete responders (TRG1–2) and overall diagnostic accuracy for each item were calculated. After neoadjuvant therapy, all patients were submitted to surgery. According to Mandard’s criteria, 21 tumors showed complete (TRG1) or subtotal regression (TRG2) and were classified as responders; nine tumors were classified as non responders (TRG3, 4, and 5). In all the patients, mean value of SUVmax in PET/CT1 was higher than those in PET/CT2 (P < 0.001), whereas mean ADC value was lower in RM1 than RM2 (P < 0.001), with a significant percentage decrease of values after the treatment (P < 0.005).The best predictors cut-off values for TRG response were SUVmax of 4.4 and ADC of 1.28 × 103 mm2/s with sensitivity, specificity accuracy, negative predictive value, and positive predictive values of 77.3%, 88.9%, 80.7%, 61.5%, and 94.4%, respectively. We conclude from the overall data of this study that the absolute values of SUVmax and ADC of rectal lesion after CRT were the best parameters to define the response to treatment, by differentiating fibrosis from viable tumor tissue.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Capirci C, Rampin L, Erba PA, et al. (2007) Sequential FDG-PET/CT reliably predicts response of locally advanced rectal cancer to neo-adjuvant chemo-radiation therapy. Eur J Nucl Med Mol Imaging 34(10):1583–1593

    Article  PubMed  CAS  Google Scholar 

  2. Late effects consensus conference: RTOG/EORTC (1995) Radiother Oncol 35(1):5–7.

    Google Scholar 

  3. Capirci C, Rubello D, Chierichetti F, et al. (2004) Restaging after neoadjuvant chemoradiotherapy for rectal adenocarcinoma: role of F18-FDG PET. Biomed Pharmacother 58(8):451–457

    PubMed  CAS  Google Scholar 

  4. Schelling M, Avril N, Nährig J, et al. (2000) Positron emission tomography using [(18)F]fluorodeoxyglucose for monitoring primary chemotherapy in breast cancer. J Clin Oncol 18(8):1689–1695

    PubMed  CAS  Google Scholar 

  5. Swisher SG, Erasmus J, Maish M, et al. (2004) 2-Fluoro-2-deoxy-d-glucose positron emission tomography imaging is predictive of pathologic response and survival after preoperative chemoradiation in patients with esophageal carcinoma. Cancer 101(8):1776–1785

    Article  PubMed  Google Scholar 

  6. Cascini GL, Avallone A, Delrio P, et al. (2006) 18F-FDG PET is an early predictor of pathologic tumor response to preoperative radiochemotherapy in locally advanced rectal cancer. J Nucl Med 47(8):1241–1248

    PubMed  CAS  Google Scholar 

  7. Hein PA, Kremser C, Judmaier W, et al. (2003) Diffusion-weighted magnetic resonance imaging for monitoring diffusion changes in rectal carcinoma during combined, preoperative chemoradiation: preliminary results of a prospective study. Eur J Radiol 45(3):214–222

    Article  PubMed  Google Scholar 

  8. Le Bihan D (1995) Molecular diffusion, tissue microdynamics and microstructure. NMR Biomed 8(7–8):375–386

    Article  PubMed  CAS  Google Scholar 

  9. Kremser C, Judmaier W, Hein P, et al. (2003) Preliminary results on the influence of chemoradiation on apparent diffusion coefficients of primary rectal carcinoma measured by magnetic resonance imaging. Strahlenther Onkol 179(9):641–649

    Article  PubMed  Google Scholar 

  10. Mandard AM, Dalibard F, Mandard JC, Marnay J, Henry-Amar M, Petiot JF, et al. (1994) Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlation. Cancer 73(11):2680–2686

    Article  PubMed  CAS  Google Scholar 

  11. Theodoropoulos G, Wise WE, Padmanabhan A, et al. (2002) T-level downstaging and complete pathologic response after preoperative chemoradiation for advanced rectal cancer result in decreased recurrence and improved disease-free survival. Dis Colon Rectum 45(7):895–903

    Article  PubMed  Google Scholar 

  12. Valentini V, Coco C, Picciocchi A, et al. (2002) Does downstaging predict improved outcome after preoperative chemoradiation for extraperitoneal locally advanced rectal cancer? A long-term analysis of 165 patients. Int J Radiat Oncol Biol Phys 53(3):664–674

    Article  PubMed  Google Scholar 

  13. Onaitis MW, Noone RB, Hartwig M, et al. (2001) Neoadjuvant chemoradiation for rectal cancer: analysis of clinical outcomes from a 13-year institutional experience. Ann Surg 233(6):778–785

    Article  PubMed  CAS  Google Scholar 

  14. Cho YB, Chun HK, Kim MJ, et al. (2009) Accuracy of MRI and 18F-FDG PET/CT for restaging after preoperative concurrent chemoradiotherapy for rectal cancer. World J Surg 33(12):2688–2694

    Article  PubMed  Google Scholar 

  15. Guerra L, Niespolo R, Di Pisa G, et al. (2011) Change in glucose metabolism measured by 18F-FDG PET/CT as a predictor of histopathologic response to neoadjuvant treatment in rectal cancer. Abdom Imaging 36(1):38–45

    Article  PubMed  Google Scholar 

  16. Sun YS, Zhang XP, Tang L, et al. (2010) Locally advanced rectal carcinoma treated with preoperative chemotherapy and radiation therapy: preliminary analysis of diffusion-weighted MR imaging for early detection of tumor histopathologic downstaging. Radiology 254(1):170–178

    Article  PubMed  Google Scholar 

  17. Kim SH, Lee JY, Lee JM, Han JK, Choi BI (2011) Apparent diffusion coefficient for evaluating tumor response to neoadjuvant chemoradiation therapy for locally advanced rectal cancer. Eur Radiol 21(5):987–995

    Article  PubMed  Google Scholar 

  18. Kim SH, Lee JM, Hong SH, et al. (2009) Locally advanced rectal cancer: added value of diffusion-weighted MR imaging in the evaluation of tumor response to neoadjuvant chemo- and radiation therapy. Radiology 253(1):116–125

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Letizia Monguzzi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ippolito, D., Monguzzi, L., Guerra, L. et al. Response to neoadjuvant therapy in locally advanced rectal cancer: assessment with diffusion-weighted MR imaging and 18FDG PET/CT. Abdom Imaging 37, 1032–1040 (2012). https://doi.org/10.1007/s00261-011-9839-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00261-011-9839-1

Keywords

Navigation